Conestoga Capital Advisors LLC Sells 2,265 Shares of Transcat, Inc. (NASDAQ:TRNS)

Conestoga Capital Advisors LLC cut its holdings in Transcat, Inc. (NASDAQ:TRNSFree Report) by 0.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 904,926 shares of the scientific and technical instruments company’s stock after selling 2,265 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 9.84% of Transcat worth $95,687,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in TRNS. Royce & Associates LP increased its position in Transcat by 8.2% in the 3rd quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after acquiring an additional 38,774 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in shares of Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after purchasing an additional 74,169 shares in the last quarter. Geode Capital Management LLC raised its position in Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after purchasing an additional 11,106 shares during the last quarter. State Street Corp lifted its holdings in Transcat by 8.1% during the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after buying an additional 15,514 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock valued at $9,577,000 after buying an additional 17,743 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Trading Up 0.4 %

Shares of TRNS opened at $77.02 on Monday. The stock has a market cap of $708.58 million, a P/E ratio of 41.63 and a beta of 0.68. Transcat, Inc. has a 1 year low of $73.37 and a 1 year high of $147.12. The stock’s 50-day moving average price is $103.15 and its two-hundred day moving average price is $113.80.

Transcat (NASDAQ:TRNSGet Free Report) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same quarter last year, the business posted $0.56 EPS. As a group, equities analysts forecast that Transcat, Inc. will post 2.3 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on TRNS shares. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and set a $85.00 price objective (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. StockNews.com raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday, January 28th. Craig Hallum boosted their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, HC Wainwright cut their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Transcat presently has an average rating of “Hold” and a consensus price target of $111.50.

Check Out Our Latest Research Report on Transcat

Transcat Profile

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Recommended Stories

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSFree Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.